You have 9 free searches left this month | for more free features.

Condition

Fibrosis (2)

Covid19 (1)

Idiopathic Pulmonary Fibrosis (1)

Sars-CoV-2 (1)

Overall Status

Completed (2)

Withdrawn (2)

Sign in for free

Phase

phase 1 (2)

phase 2 (2)

Sponsor

Blade Therapeutics (4)

Collaborator

Clinipace Worldwide (1)

Intervention

bld-2660 (4)

control: placebo (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

bld-2660

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Idiopathic Pulmonary Fibrosis Trial in London (BLD-2660, Control: Placebo)

Withdrawn

Idiopathic Pulmonary Fibrosis

BLD-2660
Control: Placebo

London, United Kingdom

Blade Research Site

Mar 2, 2021

Sars-CoV-2, Covid19 Trial in Brazil, United States (BLD-2660)

Completed

Has Results

Sars-CoV-2
Covid19

BLD-2660

Irvine, California
+34 more

Apr 1, 2022

Fibrosis Trial in Randwick (BLD-2660)

Withdrawn

Fibrosis

BLD-2660

Randwick, New South Wales, Australia

Scientia Clinical Research

Oct 29, 2020

Fibrosis Trial in Melbourne (BLD-2660)

Completed

Fibrosis

BLD-2660

Melbourne, Victoria, Australia

Nucleus Network

Mar 17, 2020